Results 161 to 170 of about 658,841 (317)
Improving productivity of modern-day drug discovery [PDF]
Matthew D. Breyer
openalex +1 more source
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero +5 more
wiley +1 more source
Generative AI in structure-based drug discovery. [PDF]
Zhong Z, Durrant JD.
europepmc +1 more source
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar +4 more
wiley +1 more source
Leveraging conformational ensembles in allosteric drug discovery. [PDF]
Nussinov R, Regev C, Jang H.
europepmc +1 more source
I-31 Prenyltransferases as targets for antibiotic drug discovery
A.H.J. Wang
openalex +1 more source
In normal (nontolerant) cells, CD14 is crucial for both LPS uptake and LPS signaling. In LPS‐tolerant cells, in which LPS‐induced TNF‐α and IFN‐β production is suppressed, there is a dramatic increase in surface CD14 expression. The overexpressed CD14 in LPS‐tolerant cells is responsible for the enhanced LPS uptake without inducing pro‐inflammatory ...
Saeka Nishihara +3 more
wiley +1 more source
Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications. [PDF]
Liu Y, Zhu K, Peng W, Liu Z, Mao X.
europepmc +1 more source
Accelerating the discovery of drugs for Neglected Tropical Diseases using biophysical methods
Giulia Opassi
openalex +1 more source

